Factor IX as Adjunctive Therapy to Emicizumab (EMIX)
Clinical trial NCT05281718 · COMPLETED
Trial details
- NCT number
- NCT05281718
- Sponsor
- Tulane University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2024-03-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.